Cargando…

Evaluation of Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Active and Inactive Thyroid Orbitopathy

OBJECTIVES: The aim of this study was to evaluate the neutrophil-to-lymphocyte ratio (NLR) and the mean platelet volume (MPV) in patients with active thyroid orbitopathy (TO) and to compare it with that of both healthy subjects and patients with inactive TO. METHODS: Twenty patients with active TO (...

Descripción completa

Detalles Bibliográficos
Autores principales: Atılgan, Cemile Üçgül, Şendül, Selam Yekta, Kösekahya, Pınar, Çağlayan, Mehtap, Alkan, Alpaslan, Güven, Dilek, Yılmazbaş, Pelin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315080/
https://www.ncbi.nlm.nih.gov/pubmed/32595367
http://dx.doi.org/10.14744/SEMB.2017.07269
_version_ 1783550186962812928
author Atılgan, Cemile Üçgül
Şendül, Selam Yekta
Kösekahya, Pınar
Çağlayan, Mehtap
Alkan, Alpaslan
Güven, Dilek
Yılmazbaş, Pelin
author_facet Atılgan, Cemile Üçgül
Şendül, Selam Yekta
Kösekahya, Pınar
Çağlayan, Mehtap
Alkan, Alpaslan
Güven, Dilek
Yılmazbaş, Pelin
author_sort Atılgan, Cemile Üçgül
collection PubMed
description OBJECTIVES: The aim of this study was to evaluate the neutrophil-to-lymphocyte ratio (NLR) and the mean platelet volume (MPV) in patients with active thyroid orbitopathy (TO) and to compare it with that of both healthy subjects and patients with inactive TO. METHODS: Twenty patients with active TO (Group 1), 25 patients with inactive TO (Group 2), and 35 age- and sex-matched healthy subjects (Group 3) were included in this study. Patients with other systemic and ocular diseases, patients with a history of intraocular or orbital surgery, and patients using systemic drugs were excluded. The VISA (vision, inflammation, strabismus, appearance) classification scheme was used to discriminate between active and inactive TO. The neutrophil and lymphocyte counts and the MPV of all participants were recorded. The NLR was calculated by dividing the neutrophil count by the lymphocyte count, and the result was compared between groups. The optimal cut-off value was determined for NLR and MPV and the data were compared with a one-way analysis of variance test and the ’Bonferroni post-test. RESULTS: The mean age was 45.4±13.4, 41.0±13.7, and 42.6±14.4 years in Group 1, 2, and 3, respectively (p=0.68). The NLR was 2.11 in Group 1, 1.56 in Group 2, and 1.47 in Group 3 (p=0.03). The ’Bonferroni post-test revealed a difference between Group 1 and Group 2 (p=0.01) and between Group 1 and Group 3 (p<0.001). The MPV was 10.76 fL in Group 1, 9.94 fL in Group 2, and 8.19 fL in Group 3 (p<0.001). The results of the ’Bonferroni post-test showed a difference between Group 1 and Group 2 (p=0.04), between Group 1 and Group 3 (p<0.001), and between Group 2 and Group 3 (p<0.001). The mean cut-off value obtained from receiver operating characteristic (ROC) analysis of NLR was 1.69 (sensitivity: 72%; specificity: 66%). The mean cut-off value obtained from ROC analysis of MPV was 9.95 (sensitivity: 63%; specificity: 66%). CONCLUSION: High NLR and MPV values may be indicative of active inflammation in patients with TO.”
format Online
Article
Text
id pubmed-7315080
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-73150802020-06-25 Evaluation of Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Active and Inactive Thyroid Orbitopathy Atılgan, Cemile Üçgül Şendül, Selam Yekta Kösekahya, Pınar Çağlayan, Mehtap Alkan, Alpaslan Güven, Dilek Yılmazbaş, Pelin Sisli Etfal Hastan Tip Bul Original Research OBJECTIVES: The aim of this study was to evaluate the neutrophil-to-lymphocyte ratio (NLR) and the mean platelet volume (MPV) in patients with active thyroid orbitopathy (TO) and to compare it with that of both healthy subjects and patients with inactive TO. METHODS: Twenty patients with active TO (Group 1), 25 patients with inactive TO (Group 2), and 35 age- and sex-matched healthy subjects (Group 3) were included in this study. Patients with other systemic and ocular diseases, patients with a history of intraocular or orbital surgery, and patients using systemic drugs were excluded. The VISA (vision, inflammation, strabismus, appearance) classification scheme was used to discriminate between active and inactive TO. The neutrophil and lymphocyte counts and the MPV of all participants were recorded. The NLR was calculated by dividing the neutrophil count by the lymphocyte count, and the result was compared between groups. The optimal cut-off value was determined for NLR and MPV and the data were compared with a one-way analysis of variance test and the ’Bonferroni post-test. RESULTS: The mean age was 45.4±13.4, 41.0±13.7, and 42.6±14.4 years in Group 1, 2, and 3, respectively (p=0.68). The NLR was 2.11 in Group 1, 1.56 in Group 2, and 1.47 in Group 3 (p=0.03). The ’Bonferroni post-test revealed a difference between Group 1 and Group 2 (p=0.01) and between Group 1 and Group 3 (p<0.001). The MPV was 10.76 fL in Group 1, 9.94 fL in Group 2, and 8.19 fL in Group 3 (p<0.001). The results of the ’Bonferroni post-test showed a difference between Group 1 and Group 2 (p=0.04), between Group 1 and Group 3 (p<0.001), and between Group 2 and Group 3 (p<0.001). The mean cut-off value obtained from receiver operating characteristic (ROC) analysis of NLR was 1.69 (sensitivity: 72%; specificity: 66%). The mean cut-off value obtained from ROC analysis of MPV was 9.95 (sensitivity: 63%; specificity: 66%). CONCLUSION: High NLR and MPV values may be indicative of active inflammation in patients with TO.” Kare Publishing 2018-03-21 /pmc/articles/PMC7315080/ /pubmed/32595367 http://dx.doi.org/10.14744/SEMB.2017.07269 Text en Copyright: © 2018 by The Medical Bulletin of Sisli Etfal Hospital http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Original Research
Atılgan, Cemile Üçgül
Şendül, Selam Yekta
Kösekahya, Pınar
Çağlayan, Mehtap
Alkan, Alpaslan
Güven, Dilek
Yılmazbaş, Pelin
Evaluation of Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Active and Inactive Thyroid Orbitopathy
title Evaluation of Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Active and Inactive Thyroid Orbitopathy
title_full Evaluation of Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Active and Inactive Thyroid Orbitopathy
title_fullStr Evaluation of Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Active and Inactive Thyroid Orbitopathy
title_full_unstemmed Evaluation of Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Active and Inactive Thyroid Orbitopathy
title_short Evaluation of Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Active and Inactive Thyroid Orbitopathy
title_sort evaluation of neutrophil-to-lymphocyte ratio and mean platelet volume in patients with active and inactive thyroid orbitopathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315080/
https://www.ncbi.nlm.nih.gov/pubmed/32595367
http://dx.doi.org/10.14744/SEMB.2017.07269
work_keys_str_mv AT atılgancemileucgul evaluationofneutrophiltolymphocyteratioandmeanplateletvolumeinpatientswithactiveandinactivethyroidorbitopathy
AT sendulselamyekta evaluationofneutrophiltolymphocyteratioandmeanplateletvolumeinpatientswithactiveandinactivethyroidorbitopathy
AT kosekahyapınar evaluationofneutrophiltolymphocyteratioandmeanplateletvolumeinpatientswithactiveandinactivethyroidorbitopathy
AT caglayanmehtap evaluationofneutrophiltolymphocyteratioandmeanplateletvolumeinpatientswithactiveandinactivethyroidorbitopathy
AT alkanalpaslan evaluationofneutrophiltolymphocyteratioandmeanplateletvolumeinpatientswithactiveandinactivethyroidorbitopathy
AT guvendilek evaluationofneutrophiltolymphocyteratioandmeanplateletvolumeinpatientswithactiveandinactivethyroidorbitopathy
AT yılmazbaspelin evaluationofneutrophiltolymphocyteratioandmeanplateletvolumeinpatientswithactiveandinactivethyroidorbitopathy